Sheena Bhimji-Hewitt MAppSc; DMS, CRGS, RDMS – Novel Corona Virus Disease-19 (nCov-19, COVID-19) was recognised as a pandemic by the World Health Organization on March 11, 2020. As of June 14, 2020, this contagious viral disease has afflicted 188 out of 195 countries in the world with 7,893,700 confirmed cases and 432,922 global deaths.Canada has 98,787 people infected and 8,146 deaths. COVID-19 is thought to transmit through contact, droplets and aerosolization. A rapid review showed limited information on the benefits of conducting lung ultrasound (LUS) versus chest radiograph (CXR) or studies correlating lung ultrasound to chest computed Tomography (CT) in patients positive for Covid-19.
by Cristina D’Alessandro PCP BA(Hons), Ian R. Drennan ACP Phd (c), Joseph Newbigging MD CCFP (EM) FCFP, Amer M. Johri MD MSc FRCPC FASE –
Portable ultrasound is a burgeoning technology with unrealized potential at a critical point in its evolution . Francis Galton first generated ultrasound waves in 1876; however, it wasn’t until 1940 that ultrasound was first applied to clinical medicine . Reaching a “tipping point”, ultrasound is being rapidly assimilated into many medical specialties beyond radiology, now in the hands of non-radiologist, non-cardiologist novel users .